moved for leave to introduce Bill C-239, an act to amend the Food and Drugs Act (process for approval of new drugs)
Mr. Speaker, this bill would effectively improve the process of drug approval in Canada. It would speed up the process.
The model that I am looking at in this bill would correspond very closely to the one in the European Community.
There would be an absolute benefit to Canada. The sooner that drugs get on the market and become available to Canadians, the sooner that diseases will be cured and people will not be hospitalized for as long a time. There would be real benefits to Canadians if this bill were passed by the House of Commons.
(Motions deemed adopted, bill read the first time and printed)